Tag: mRNA

October 16, 2023

During the COVID-19 crisis, innovative mRNA vaccines stepped into the spotlight, with media outlets reporting on every stage of their development, distribution and delivery to patients. These new mRNA vaccines had to be kept cold throughout their shipment and storage: […]

March 17, 2023

Vaccine effectiveness provided by boosters waned less against severe disease than against moderate disease in all age groups according to the new study which was conducted by the Centers for Disease Control and Prevention’s (CDC) VISION Network. “While there have […]

May 17, 2022

A comparison of four COVID-19 vaccinations shows that messenger RNA (mRNA) vaccines — Pfizer-BioNTech and Moderna — perform better against the World Health Organization’s variants of concern (VOCs) than viral vector vaccines — AstraZeneca and J&J/Janssen. Although they all effectively […]

February 21, 2022

Proteins need to interact in a complex manner for a so-called “messenger RNA” (mRNA) to be created in human cells from a precursor molecule. mRNA provides a blueprint for proteins; the first vaccines against the coronavirus are also based on […]

February 11, 2022

A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity against severe COVID-19 disease begins to wane 4 months after receipt of the third dose of an mRNA vaccine (Pfizer […]

February 7, 2022

Mainz Biomed has initiated the ColoFuture clinical study to assess the integration of a new mRNA biomarkers portfolio into its ColoAlert test for colorectal cancer (CRC). ColoAlert is an easy-to-use, non-invasive test designed to detect tumour DNA and CRC cases […]

October 8, 2021

Coronavirus disease 2019 (COVID-19) spread worldwide in 2019, throwing many countries into economic crises as they attempted to control the spread of the disease with lockdowns, social distancing, and other restrictions. Mass vaccination schemes have begun to help bring the […]

August 2, 2021

Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based coronavirus disease 2019 (COVID-19) vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of […]

July 6, 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic and has been identified as the third human coronavirus outbreak of the 21st century. Though predominantly a respiratory virus, SARS-CoV-2 can […]

March 17, 2020

The race is on to develop an immunization against COVID-19. Dozens of companies and public labs around the world are working to develop a vaccine to prevent the spread of the flu-like virus. Over the last 48 hours, three biotech […]